FDA News

Latest News

FDA
FDA Approves Merilog, Biosimilar Product of Insulin Aspart (Novolog) for Diabetes

February 14th 2025

On February 14, 2025, the FDA approved the first rapid-acting biosimilar insulin product called nsulin-aspart-szjj (Merilog).

FDA Approval Announced for 2 New Injectable Hyaluronic Acid, Dermal Filler Gels
FDA Approval Announced for 2 New Injectable Hyaluronic Acid, Dermal Filler Gels

February 13th 2025

FDA Approves Expanded Label for Avacincaptad Pegol  | Image Credit: US Food and Drug Administration
FDA Expands Dosing Label for Avacincaptad Pegol for Geographic Atrophy

February 13th 2025

Kidney Disease stock imagery. | Credit: Adobe Stock
Travere Therapeutics Plans FSGS Submission for Sparsentan

February 11th 2025

FDA Grants Fast-Track Designation to Rezpegaldesleukin for Atopic Dermatitis
FDA Grants Fast Track Designation to Rezpegaldesleukin for Atopic Dermatitis

February 10th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.